Anti-inflammatory therapy for recurrent in-stent restenosis (AI-ISR): study protocol for a prospective, randomised, open-label, multicentre clinical trial
Authors
Z. Wei (ORCID: https://orcid.org/0000-0001-6523-6485)
National Key Research and Development Program of China
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Anti-inflammatory therapy for recurrent in-stent restenosis (AI-ISR): study protocol for a prospective, randomised, open-label, multicentre clinical trial
Z. Wei, Haiyan Qian, Fasheng Zhu, Yu Jiang et al.
Citations
1 citations
Journal
BMJ Open
Topics
Coronary Interventions and Diagnostics
Field-Weighted Citation Impact (FWCI)
2.01
article
Anti-inflammatory therapy for recurrent in-stent restenosis (AI-ISR): study protocol for a prospective, randomised, open-label, multicentre clinical trial
Z. Wei, Haiyan Qian, Fasheng Zhu, Yu Jiang, Fangshun Tan, Yanpu Shi, Xiaoyan Liu, Ji Huang, Xuan Zhang, Zhifeng Song, Weixian Yang, Miao Yu
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(10)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Beijing Anzhen Hospital (CN), Fu Wai Hospital (CN)
Funders
China Association for Science and Technology, Chinese Academy of Medical Sciences, National Key Research and Development Program of China